Evidence map›Paper›PMID 35867842›Full record

Observational studyJMIR mHealth and uHealth2022

Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study.

Feiko Ritsema, Jizzo R Bosdriesz, Tjalling Leenstra, Mariska W F Petrignani, Liza Coyer, Anja J M Schreijer, Yvonne T H P van Duijnhoven, Janneke H H M van de Wijgert, Maarten F Schim van der Loeff, Amy Matser

Abstract readObservational Study
In one paragraph

Observational study in JMIR mHealth and uHealth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Feiko RitsemaDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-2570-4074
Jizzo R BosdrieszDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-1038-7814
Tjalling LeenstraDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-7294-2193
Mariska W F PetrignaniDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-8806-9867
Liza CoyerDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-5830-2982
Anja J M SchreijerDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-6392-7637
Yvonne T H P van DuijnhovenDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-1950-5378
Janneke H H M van de WijgertJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.ORCID 0000-0003-2728-4560
Maarten F Schim van der LoeffDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-4903-7002
Amy MatserDepartment of Infectious Diseases, GGD Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-4291-1905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWorldwide, efforts are being made to stop the COVID-19 pandemic caused by SARS-CoV-2. Contact tracing and quarantining are key in limiting SARS-CoV-2 transmission. Mathematical models have shown that the time between infection, isolation of cases, and quarantining of contacts are the most important components that determine whether the pandemic can be controlled. Mobile contact-tracing apps could accelerate the tracing and quarantining of contacts, including anonymous contacts. However, real-world observational data on the uptake and determinants of contact-tracing apps are limited.

objectiveThe aim of this paper is to assess the use of a national Dutch contact-tracing app among notified cases diagnosed with SARS-CoV-2 infection and investigate which characteristics are associated with the use of the app.

methodsDue to privacy regulations, data from the app could not be used. Instead, we used anonymized SARS-CoV-2 routine contact-tracing data collected between October 28, 2020, and February 26, 2021, in the region of Amsterdam, the Netherlands. Complete case logistic regression analysis was performed to identify which factors (age, gender, country of birth, municipality, number of close contacts, and employment in either health care or education) were associated with using the app. Age and number of close contacts were modelled as B-splines due to their nonlinear relationship.

resultsOf 29,766 SARS-CoV-2 positive cases, 4824 (16.2%) reported app use. Median age of cases was 41 (IQR 29-55) years, and 46.7% (n=13,898) were male. In multivariable analysis, males (adjusted odds ratio [AOR] 1.11, 95% CI 1.04-1.18) and residents of municipalities surrounding Amsterdam were more likely to use the app (Aalsmeer AOR 1.34, 95% CI 1.13-1.58; Ouder-Amstel AOR 1.96, 95% CI 1.54-2.50), while people born outside the Netherlands, particularly those born in non-Western countries (AOR 0.33, 95% CI 0.30-0.36), were less likely to use the app. Odds of app use increased with age until the age of 58 years and decreased sharply thereafter (P<.001). Odds of app use increased with number of contacts, peaked at 8 contacts, and then decreased (P<.001). Individuals working in day care, home care, and elderly nursing homes were less likely to use the app.

conclusionsContact-tracing app use among people with confirmed SARS-CoV-2 infection was low in the region of Amsterdam. This diminishes the potential impact of the app by hampering the ability to warn contacts. Use was particularly low among older people, people born outside the Netherlands, and people with many contacts. Use of the app was also relatively low compared to those from some other European countries, some of which had additional features beyond contact tracing, making them potentially more appealing. For the Dutch contact-tracing app to have an impact, uptake needs to be higher; therefore, investing more into promotional efforts and additional features could be considered.

Indexed as

COVID-19SARS-CoV-2AdultAgedContact TracingFemaleHumansMaleMiddle AgedNetherlandsPandemicscontact tracingcontact tracing appCOVID-19digital healthhealth applicationsmHealthmobile applicationsmobile contact tracing apppandemicpublic healthsurveillance

Identifiers

PMID35867842
PMCPMC9407157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.